Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Journal, Physical Therapy Education|March 13, 2024
Building a Foundation for Health Informatics Content in Physical Therapy Education Through Concept Analysis and Concept MappingJulia Chevan, Sang S Pak, Steven G Wilkinson, et al.
CNS Neuroscience & Therapeutics|January 5, 2011
The upside of APP at synapsesHyang-Sook Hoe, Hey-Kyoung Lee, Daniel T S Pak
Neuroscience Letters|November 9, 2010
Embryonic stem cells inhibit expression of erythropoietin in the injured spinal cordMargarita Glazova, Sarah Hollis, Elena S Pak, et al.
The Journal of Emergency Medicine|August 23, 2011
Pneumoperitoneum after sexual assault in a patient who had hysterectomy 30 years ago: case reportDaniel D Im, Peter S Pak, Bennett Cua, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1994
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alphaM R Young, G McCloskey, M A Wright, et al.
Diseases of Aquatic Organisms|July 25, 2000
Monitoring Piscirickettsia salmonis by denaturant gel electrophoresis and competitive PCRS Heath, S Pak, S Marshall, et al.
Virology|August 20, 1995
The virion host shutoff protein of herpes simplex virus inhibits reporter gene expression in the absence of other viral gene productsA S Pak, D N Everly, K Knight, et al.
Clinical Nuclear Medicine|April 1, 1996
Giant infantile hemangioendothelioma of the liver. Scintigraphic diagnosisC H Park, H S Hwang, J Hong, et al.
Neuroscience Letters|December 17, 2011
Multi-walled carbon nanotubes inhibit regenerative axon growth of dorsal root ganglia neurons of miceDi Wu, Elena S Pak, Christopher J Wingard, et al.
Cancer Research|February 15, 1995
Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapyA S Pak, G Ip, M A Wright, et al.
Pageof 21